Glipizide
- Product NDC
- 51655-361
- 11-digit product format
- 516550361
- Labeler code
- 51655
- Product ID
- 51655-361_d4792b1b-f6c4-5b55-e053-2a95a90a0d35
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- glipizide
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Northwind Pharmaceuticals
- Application
- NDA020329
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2020-05-28
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-361 | GLIPIZIDE XL (GLIPIZIDE) TABLET, EXTENDED RELEASE [NORTHWIND PHARMACEUTICALS, LLC] | 3 | Legacy NDC | 20231219_ab6e676b-577d-79a4-e053-2995a90acda8.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51655-361-26 | 51655036126 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-361-26) | 2020-05-28 | 0000-00-00 | No | No | Current |